Pipeline
![](/front/assets/common/images/product/img_sub_product_pipelineBiosimilar_kv.png)
![](/front/assets/common/images/product/img_sub_product_pipelineBiosimilar_kv_mo.png)
Biosimilars
Project Name INN Indications Clinical Info
- Project NameCT-P51
- INNPembrolizumab
- Indications Melanoma, lung cancer, stomach canc
- Clinical InfoPhase 3
It is not intended for product promotion or sales. For more information, contact your doctor or healthcare professional.